Private AI: Architecting Secure, Compliant Life Sciences and Healthcare Solutions
IDC Guest Post The life sciences and the healthcare (LSH) industries have seen immense potential in what AI has to offer and are investing significantly in AI.[1] [NL2] Deep Pharma Intelligence has reported that the cumulative investments in AI-related drug development between 2014 and 2023 topped $60 billion. AI, and GenAI in particular, have caught […]